Pasar al contenido principal

FUNCION DE LSECTIN EN LA RESTRICCION DE LA TRANSICION DESDE LA RESPUESTA INNATA A LA RESPUESTA ADAPTATIVA PATOGENICA POR CELULAS T CD4+ EN CIRRHOSIS

PID2019-107036RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endocrine disruption in Crohn’s disease: Bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products

  • Linares, Raquel
  • Fernández, Mariana F.
  • Gutiérrez, Ana
  • García-Villalba, Rocío
  • Suárez, Beatriz
  • Zapater, Pedro
  • Martínez-Blázquez, J. Alberto
  • Caparrós, Esther
  • Tomás Barberán, Francisco
  • Francés, Rubén
The relevance of environmental triggers in Crohn's disease remains poorly explored, despite the well-known association between industrialization and disease onset/progression. We have aimed at evaluating the influence of endocrine disrupting chemicals in CD patients. We performed a prospective observational study on consecutive patients diagnosed of CD. Serum levels of endocrine disruptors, short-chain fatty acids, tryptophan and cytokines were measured. Bacterial-DNA and serum endotoxin levels were also evaluated. Gene expression of ER-α, ER-β and GPER was measured in PBMCs. All patients were genotyped for NOD2 and ATG16L1 polymorphisms. A series of 200 CD patients (140 in remission, 60 with active disease) was included in the study. Bisphenol A was significantly higher in patients with active disease versus remission and in colonic versus ileal disease. GPER was significantly increased in active patients and correlated with BPA levels. BPA was significantly increased in patients with bacterial-DNA and correlated with serum endotoxin levels, (r = 0.417; P =.003). Serum butyrate and tryptophan levels were significantly lower in patients with bacterial-DNA and an inverse relationship was present between them and BPA levels (r = −0.491; P =.001) (r = −0.611; P =.001). Serum BPA levels correlated with IL-23 (r = 0.807; P =.001) and IL-17A (r = 0.743; P =.001). The multivariate analysis revealed an independent significant contribution of BPA and bacterial-DNA to serum levels of IL-23 and IL-17A. In conclusion, bisphenol A significantly affects systemic inflammatory response in CD patients with gut barrier disruption and dysbiotic microbiota secretory products in blood. These results provide evidence of an endocrine disruptor playing an actual pathogenic role on CD., This study has been partially funded by PID2019- 107036RB-I00, from Ministerio de Ciencia, Innovación y Universidades, Madrid, Spain, and 2020-0287, from IIS ISABIAL, Hospital General Universitario, Alicante, Spain. RL is recipient of a grant (FPU 18/00063) by Ministerio de Ciencia, Innovación y Universidades, Madrid, Spain
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response

  • Martínez-López, Sebastián
  • Ángel-Gomis, Enrique
  • Gómez-Hurtado, Isabel
  • Fernández-Iglesias, Anabel
  • Morante, Javier
  • Gracia-Sancho, Jordi
  • Boix, Paula
  • Cubero, Francisco Javier
  • Zapater, Pedro
  • Caparrós, Esther
  • Francés, Rubén
[Background and aims]: We evaluated tolerogenic C-type lectin LSECtin loss in cirrhosis and its potential regulation by cytokines., [Methods]: Liver tissue from patients with cirrhosis and healthy controls, immortalised and generated LSECtin-CRISPR immortalised LSECs, and murine primary LSECs from the CCl4 model were handled., [Results]: LSECtin expression was reduced in liver tissue from cirrhotic patients, and it decreased from compensated to decompensated disease. Increased phosphorylation of MAPK, Akt and NFkB was observed upon LSECtin stimulation in LSEC murine cell line, showing a pattern of inflammatory and chemotactic cytokines either restrained (IL-10, CCL4) or unrestrained (TNF-α, IL-1β, IL-6, CCL2). CD44 attenuated whereas LAG-3 increased all substrates phosphorylation in combination with TLR4 and TLR2 ligands except for NFkB. TNF-α, IL-1 β, IL-6 and CCL2 were restrained by LSECtin crosslinking on TLRs studied. Conversely, IL-10 and CCL4 were upregulated, suggesting a LSECtin-TLRs synergistic effect. Also, LSECtin was significantly induced after IL-13 stimulation or combined with anti-inflammatory cytokines in cirrhotic and immortalised LSECs. Th17 and regulatory T cells were progressively increased in the hepatic tissue from compensated to decompensated patients. A significant inverse correlation was present between gene expression levels of CLEC4G/LSECtin and RORγT and FOXP3 in liver tissues., [Conclusion]: LSECtin restrains TLR proinflammatory secretome induced on LSECs by interfering immune response control, survival and MAPKs signalling pathways. The cytokine-dependent induction of LSECtin and the association between LSECtin loss and Th17 cell subset expansion in the liver, provides a solid background for exploring LSECtin retrieval as a mechanism to reprogram LSEC homeostatic function hampered during cirrhosis., This work was supported by grants from the Ministerio de Ciencia e Innovación PID2019-107036RB-I00 and PID2020-117941RB-I00, Instituto de Salud Carlos III PMP21/0082, PI20/00220 and DTS22/00010, EU Horizon-HLTH-2022-STAYHLTH-02 under agreement No. 101095679, Generalitat Valenciana Prometeo 2021/033, Comunidad de Madrid ExoHep2 S2022/BMD-7409 and AGAUR-Generalitat Catalunya (2021 SGR 01322 and 2021 PROD 00036). CIBEREHD is funded by the Instituto de Salud Carlos III using grants cofinanced by the European Development Regional Fund “A way to achieve Europe” (EDRF)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

The 3Rs in Experimental Liver Disease

  • Martinez-Lopez, Sebastian|||0000-0003-1720-845X
  • Ángel-Gomis, Enrique|||0000-0003-0736-7625
  • Sánchez, Elisabet|||0000-0002-3280-9301
  • Pastor-Campos, Alberto|||0000-0002-6932-8819
  • Picó, Joanna|||0000-0003-0909-8094
  • Gomez-Hurtado, Isabel|||0000-0003-4305-9427
Patients with cirrhosis present multiple physiological and immunological alterations that play a very important role in the development of clinically relevant secondary complications to the disease. Experimentation in animal models is essential to understand the pathogenesis of human diseases and, considering the high prevalence of liver disease worldwide, to understand the pathophysiology of disease progression and the molecular pathways involved, due to the complexity of the liver as an organ and its relationship with the rest of the organism. However, today there is a growing awareness about the sensitivity and suffering of animals, causing opposition to animal research among a minority in society and some scientists, but also about the attention to the welfare of laboratory animals since this has been built into regulations in most nations that conduct animal research. In 1959, Russell and Burch published the book "The Principles of Humane Experimental Technique", proposing that in those experiments where animals were necessary, everything possible should be done to try to replace them with non-sentient alternatives, to reduce to a minimum their number, and to refine experiments that are essential so that they caused the least amount of pain and distress. In this review, a comprehensive summary of the most widely used techniques to replace, reduce, and refine in experimental liver research is offered, to assess the advantages and weaknesses of available experimental liver disease models for researchers who are planning to perform animal studies in the near future.